Venous thromboembolism - rivaroxaban
Rivaroxaban for the prevention of venous thromboembolism
Summary
This guidance is about when rivaroxaban should be used to reduce the risk of thromboembolism in adults who have surgery to replace their hip or knee joints in the NHS in England and Wales. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence). It does no ...
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in February 2012
About this guidance
Technology appraisals TA170
Issued: April 2009
How this guidance was produced
